Drugs to extend dog lifespan.
Join the X-Thousand Dogs study, the largest epigenetic study in dogs, to discover more about your dog and aging science alongside us. https://loyalfordogs.com/x-thousand/
Join the X-Thousand Dogs study, the largest epigenetic study in dogs, to discover more about your dog and aging science alongside us. https://loyalfordogs.com/x-thousand/
Employees: 11-50
Total raised: $72M
Investors 16
Show more
Funding Rounds 2
| Date | Series | Amount | Investors |
| 21.03.2024 | Series B | $45M | - |
| 23.09.2021 | - | $27M | - |
Mentions in press and media 14
| Date | Title | Description |
| 29.08.2026 | Bryan Johnson tackled human longevity. Now he wants dogs to live forever. | Tech entrepreneur Bryan Johnson has become famous for his mission to help humans live forever, with his catchphrase "Don't die." Now he wants to do the same thing for dogs. Johnson's interest in canine longevity was piqued when he... |
| 25.03.2024 | Loyal Raises $45M in Series B Financing | Loyal, a biotech company in San Francisco, has secured $45 million in Series B funding to develop drugs for dogs. Led by CEO Celine Halioua, the company aims to extend the lifespan of dogs by targeting the mechanisms of aging. With three dr... |
| 21.03.2024 | Loyal raises $45 million | Loyal, a biotech startup on a mission to increase the life span of dogs, has raised $45 million in a Series B round led by Bain Capital Ventures. This brings total funding raised by Loyal to more than $125 million and includes a $12 million... |
| 21.03.2024 | Loyal Raises $45M in Series B Financing | Dr. Ellen Ratcliff, Veterinarian and Director of Clinical Development at Loyal, with Boston, a seven-year-old Beagle mix. Loyal today announced $45 million in new funding. (Photo: Business Wire) Loyal, a San Francisco, CA-based biotech comp... |
| 01.02.2024 | The first anti-aging pill for dogs is entering trials — and an 11-year-old whippet named Boo is the first to try it | Health The first anti-aging pill for dogs is entering trials — and an 11-year-old whippet named Boo is the first to try it Hilary Brueck 2024-02-01T16:01:01Z Share icon An curved arrow pointing right. Share Facebook Icon The letter F. Faceb... |
| 28.11.2023 | An anti-aging drug for dogs promises to win owners more time with old pets. It could be FDA-approved soon. | Celine Halioua founded a biotech startup developing drugs to extend dog lifespans. Courtesy of Loyal Redeem now Loyal is developing drugs to extend doggie lifespans. One drug just cleared a key FDA hurdle, a sign the agency is ready to take... |
| 17.08.2023 | Startup is developing a pill intended to help large dogs live longer | San Francisco-based Loyal is working on a new drug it hopes will help large dogs live healthier, longer lives. Driving the news: Loyal recently partnered with pharmaceutical company Crinetics to get exclusive veterinary access to its compou... |
| 19.01.2022 | How Arab Women Are Making Waves In Tech | multi-ethnic businesswomen getty |
| 23.09.2021 | How Toast came back from the brink | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. A year and a half ago, restaurant software maker Toast laid off nearly half its workforce and fur... |
| 23.09.2021 | Loyal raises $27M, aims to give dog owners more time with their pets | San Francisco startup Loyal is rethinking the concept of longevity and starting with man’s best friend. The company raised $27 million in Series A funding in a round, led by Khosla Ventures and including First Round Capital, Box Group, Coll... |
Show more